Implication of preoperative glycosylated hemoglobin level on short term outcomes in diabetic patients undergoing coronary artery bypass grafting
DOI:
https://doi.org/10.18203/2349-2902.isj20204418Keywords:
HbA1c, Diabetes mellitus, CABG, OutcomesAbstract
Background: Diabetes mellitus is one of the significant risk factors for adverse outcomes after coronary artery bypass surgery. The glycosylated haemoglobin i.e. HbA1c is a reliable diagnostic test to know the long-term glycemic status. The objective of the study is to investigate the implication of preoperative HbA1c level on short term outcomes after coronary artery bypass grafting (CABG).
Method: Total 218 patients were studied, and the data were collected retrospectively. Patients are distributed into group 1 with HbA1c≤7 (good glycemic control) and group 2 with HbA1c>7 (poor glycemic control). The parameters studied for short term outcomes were revision due to bleeding, duration of mechanical ventilation, cerebrovascular accident (CVA), atrial fibrillation (AF), renal failure requiring dialysis, infective complications like sternal and leg wound infection, mediastinitis, pneumonia, urinary tract infection (UTI), sepsis; length of ICU stay and in-hospital mortality.
Result: In comparison to group 1, patients of group 2 showed statistically significant more morbidity in view of short-term outcomes in this study.
Conclusion: HbA1c>7 is associated with statistically significant adverse short-term outcomes after CABG.
References
Zhang X, Wu Z, Peng X, Wu A, Yue Y, Martin J et al. Prognosis of diabetic patients undergoing coronary artery bypass surgery compared with nondiabetics: a systematic review and meta -analysis. J Cardiothoracic Vascular Anesthesia. 2011;25(2):288-98.
Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Kerendi F, Song HK et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thoracic Cardiovasc Surg. 2008;136(3):631-40.
Arslan U, Memetoğlu ME, Kutlu R, Erbasan O, Tort M, Çalık ES et al. Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery. Russian Open Med J. 2015;4:e0204.
Schnack C, Festa A, Schwarzmaier-D'Assié A, Haber P, Schernthaner G. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron. 1996;74:395-400.
Hjalmarsson C, Manhem K, Bokemark L, Andersson B. The role of prestroke glycemic control on severity and outcome of acute ischemic stroke. Res Treat. 2014;2014:694569.
Kinoshita T, Asai T, Suzuki T, Kambara A, Matsubayashi K. Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary artery bypass surgery. Eur J Cardiothoracic Surg. 2012;41(1):102-7.
Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010;25(8):853-8.
Alserius T, Anderson R, Hammar N, Nordqvist T, Ivert T. Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery. Scand Cardiovasc J. 2008;42(6):392-8.
Brandt M, Harder K, Walluscheck KP, Fraund S, Böning A, Cremer J. Coronary artery bypass surgery in diabetic patients. J Card Surg. 2004;19(1):36-40.
